Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.41B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$818M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$658M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$415M |
| 5 |
Microsoft
MSFT
|
+$400M |
Top Sells
| 1 |
The Communication Services Select Sector SPDR Fund
XLC
|
+$349M |
| 2 |
Consolidated Edison
ED
|
+$158M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$151M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$148M |
| 5 |
Chevron
CVX
|
+$131M |
Sector Composition
| 1 | Technology | 15.79% |
| 2 | Financials | 10.59% |
| 3 | Healthcare | 10.41% |
| 4 | Communication Services | 8.58% |
| 5 | Consumer Discretionary | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
International Money Express
IMXI
$430M
| $543K | ﹤0.01% |
38,474
+21,271
| +124% | +$300K |
|
|
ALLK
2602
DELISTED
Allakos
ALLK
| $541K | ﹤0.01% |
12,463
+5,562
| +81% | +$241K |
|
|
QTNT
2603
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $541K | ﹤0.01% |
1,447
-446
| -24% | -$167K |
|
|
NVEE
2604
DELISTED
NV5 Global
NVEE
| $540K | ﹤0.01% |
26,536
+11,524
| +77% | +$235K |
|
|
RVNC
2605
DELISTED
Revance Therapeutics, Inc.
RVNC
| $538K | ﹤0.01% |
41,503
+8,026
| +24% | +$104K |
|
|
CCF
2606
DELISTED
Chase Corporation
CCF
| $537K | ﹤0.01% |
4,993
+2,150
| +76% | +$231K |
|
2607
Comscore
SCOR
$34.1M
| $534K | ﹤0.01% |
5,178
-1,605
| -24% | -$166K |
|
2608
Precision BioSciences
DTIL
$54.3M
| $533K | ﹤0.01% |
+1,341
| New | +$533K |
|
2609
South Plains Financial
SPFI
$646M
| $532K | ﹤0.01% |
+32,257
| New | +$532K |
|
2610
Team
TISI
$81.8M
| $532K | ﹤0.01% |
3,477
+323
| +10% | +$49.4K |
|
2611
Columbia Financial
CLBK
$1.6B
| $531K | ﹤0.01% |
35,209
+19,998
| +131% | +$302K |
|
2612
Liberty Latin America Class A
LILA
$1.5B
| $531K | ﹤0.01% |
32,723
+3,429
| +12% | +$55.6K |
|
2613
Madrigal Pharmaceuticals
MDGL
$9.63B
| $528K | ﹤0.01% |
5,041
+1,693
| +51% | +$177K |
|
2614
Tredegar Corp
TG
$279M
| $525K | ﹤0.01% |
31,619
+12,310
| +64% | +$204K |
|
2615
Tenaris
TS
$18.7B
| $525K | ﹤0.01% |
19,940
-40,861
| -67% | -$1.08M |
|
|
ERF
2616
DELISTED
Enerplus Corporation
ERF
| $525K | ﹤0.01% |
69,668
+736
| +1% | +$5.55K |
|
|
FENG
2617
Phoenix New Media
FENG
$30.7M
| $524K | ﹤0.01% |
26,872
-1,004
| -4% | -$19.6K |
|
|
AVX
2618
DELISTED
AVX Corporation
AVX
| $520K | ﹤0.01% |
31,322
+10,583
| +51% | +$176K |
|
2619
Eldorado Gold
EGO
$5.7B
| $519K | ﹤0.01% |
89,265
-15,651
| -15% | -$91K |
|
2620
OneSpan
OSPN
$588M
| $519K | ﹤0.01% |
36,622
+36,607
| +244,047% | +$519K |
|
2621
Viking Therapeutics
VKTX
$2.79B
| $519K | ﹤0.01% |
62,529
+45,264
| +262% | +$376K |
|
|
ITCI
2622
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $518K | ﹤0.01% |
39,914
+14,258
| +56% | +$185K |
|
|
LCI
2623
DELISTED
Lannett Company, Inc.
LCI
| $517K | ﹤0.01% |
21,317
-5,383
| -20% | -$131K |
|
2624
AXIS Capital
AXS
$7.75B
| $516K | ﹤0.01% |
8,628
-42,423
| -83% | -$2.54M |
|
|
ACOR
2625
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $513K | ﹤0.01% |
559
+251
| +81% | +$230K |
|